A COVERED CORONARY STENT FOR ACUTE PERFORATION AFTER A PERCUTANEOUS CORONARY INTERVENTION DUE TO CARDIAC ALLOGRAFT

Mario Udovičić1,2, Hrvoje Falak1, Miro Raguž1

  • 1Department of Cardiovascular Diseases, University Hospital Dubrava, Zagreb.

PubMed

Insights

Cardiac allograft vasculopathy (CAV) is a common complication after heart transplantation (HTx). This case report details a successful intervention for coronary perforation during percutaneous coronary intervention for CAV.

Area of Science:

  • Cardiology
  • Transplantation Immunology

Background:

  • Cardiac allograft vasculopathy (CAV) is a significant cause of late graft failure and mortality post-heart transplantation (HTx).
  • It is characterized by diffuse concentric narrowing of coronary arteries due to intimal fibriproliferation.
  • CAV affects a substantial proportion of heart transplant recipients within 10 years.

Observation:

  • A 33-year-old patient with newly diagnosed CAV underwent percutaneous coronary intervention (PCI) for the circumflex coronary artery.
  • During the PCI procedure, a coronary perforation occurred.
  • The perforation was successfully managed with the deployment of a covered single stent.

Findings:

  • The covered stent effectively sealed the coronary perforation.
  • This intervention allowed for continued management of CAV in a complex post-transplant setting.

Implications:

  • This case highlights the successful use of covered stents to manage coronary perforation during PCI for CAV.
  • It suggests a viable treatment option for complications arising during interventional procedures in CAV patients.
  • Further research may explore the long-term outcomes of this technique in managing CAV-related complications.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753